Daiwa Securities Group’s Dova Pharmaceuticals DOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-183
Closed -$5K – 1274
2019
Q3
$5K Buy
183
+41
+29% +$664 ﹤0.01% 1084
2019
Q2
$2K Hold
142
– – ﹤0.01% 1167
2019
Q1
$1K Hold
142
– – ﹤0.01% 1179
2018
Q4
$1K Hold
142
– – ﹤0.01% 1140
2018
Q3
$3K Hold
142
– – ﹤0.01% 1119
2018
Q2
$4K Hold
142
– – ﹤0.01% 1115
2018
Q1
$4K Buy
+142
New +$4.25K ﹤0.01% 1098

Daiwa Securities Group's DOVA Position: Q4 2019 in Review

Daiwa Securities Group sold out of Dova Pharmaceuticals (DOVA) in Q4 2019, closing a stake of 183 shares — an estimated $5K sold.

Daiwa Securities Group first reported a position in DOVA in Q1 2018 and held it in 7 quarters. The position peaked at $5K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • Daiwa Securities Group reported no remaining Dova Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Daiwa Securities Group sold 183 Dova Pharmaceuticals shares in Q4 2019, an estimated $5K.
  • Daiwa Securities Group first reported a position in Dova Pharmaceuticals in Q1 2018 and held it in 7 quarters.
  • Daiwa Securities Group's Dova Pharmaceuticals position peaked at $5K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals as of Q4 2019.

Based on Daiwa Securities Group's 13F filing for Q4 2019, filed 31 Jan 2020.